Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-50503

Single-particle
2.84 Å
EMD-50503 Deposition: 31/05/2024
Map released: 14/08/2024
Last modified: 02/07/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-50503

Omicron BA.1 Spike protein with neutralizing NTD specific mAb K501SP6

EMD-50503

Single-particle
2.84 Å
EMD-50503 Deposition: 31/05/2024
Map released: 14/08/2024
Last modified: 02/07/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2, Enterobacteria phage T4
Sample: Alphacoronavirus
Fitted models: 9fjk

Deposition Authors: Bjoernsson KH , Walker MR , Raghavan SSR , Ward AB , Barfod LK
Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages.
PUBMED: 39354108
DOI: doi:10.1038/s42003-024-06951-7
ISSN: 2399-3642
Grant Support: